U-Blot® Research Grade Anti-Human CD198/CCR8 (SRF114)Cat. No. WA1384Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD198/CCR8 (SRF114)Cat. No. WA1384
U-Blot® Research Grade Anti-Human CD198/CCR8 (HFB101110)Cat. No. WA1383
U-Blot® Research Grade Anti-Human CD198/CCR8 (GS-1811/JTX-1811)Cat. No. WA1382
U-Blot® Research Grade Anti-Human CD198/CCR8 (FPA157)Cat. No. WA1381
U-Blot® Research Grade Anti-Human CD198/CCR8 (CM369)Cat. No. WA1380
U-Blot® Research Grade Anti-Human CD198/CCR8 (BMS-986340)Cat. No. WA1379
U-Blot® Research Grade Anti-Human CD197/CCR7 (JBH492)Cat. No. WA1378
U-Blot® Research Grade Anti-Human CD197/CCR7 (CAP-100)Cat. No. WA1377
U-Blot® Research Grade Anti-Human CD195/CCR5 (HGS1025)Cat. No. WA1376
U-Blot® Research Grade Anti-Human CD195/CCR5 (HGS101)Cat. No. WA1375
U-Blot® Research Grade Anti-Human CD194/CCR4 Antibody (KM3060)Cat. No. WA1374
U-Blot® Research Grade Anti-Human CD19 Antibody (Immunomedics hA19)Cat. No. WA1373